![Philippe van Holle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe van Holle
Nessuna posizione attualmente
Storia della carriera di Philippe van Holle
Precedenti posizioni note di Philippe van Holle
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARGOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 13/11/2014 | 13/12/2016 |
Independent Dir/Board Member | 13/11/2014 | 13/12/2016 | |
Celgene International SARL
![]() Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the company is based in Boudry, Switzerland. | Presidente | 23/06/2010 | 01/10/2014 |
Amsterdam Molecular Therapeutics (AMT) Holding NV
![]() Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Direttore/Membro del Consiglio | 23/06/2010 | 11/03/2013 |
Fondatore | 15/12/2010 | 11/03/2013 | |
Amgen Europe BV
![]() Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The company is based in Breda, Netherlands. | Corporate Officer/Principal | - | - |
Formazione di Philippe van Holle
Cornell University | Masters Business Admin |
University of Antwerp | Undergraduate Degree |
Statistiche
Distribuzione geografica
Paesi Bassi | 3 |
Stati Uniti | 3 |
Svizzera | 2 |
Posizioni
Director/Board Member | 2 |
Founder | 1 |
President | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
![]() Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
Celgene International SARL
![]() Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the company is based in Boudry, Switzerland. | Health Technology |
Amgen Europe BV
![]() Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The company is based in Breda, Netherlands. | Distribution Services |
Argos Therapeutics, Inc.
![]() Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Philippe van Holle
- Esperienza